Pulmonary Drug Delivery Devices Market Report 2026
Pulmonary Drug Delivery Devices Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Pulmonary Drug Delivery Devices Market Report 2026

Global Outlook – By Product Type (Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers), By Application (Asthma, Cystic Fibrosis, Chronic Obstructive Pulmonary Disease, Other Applications), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, E-Commerce) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Pulmonary Drug Delivery Devices Market Overview

• Pulmonary Drug Delivery Devices market size has reached to $52.8 billion in 2025

• Expected to grow to $71.9 billion in 2030 at a compound annual growth rate (CAGR) of 6.2%

• Growth Driver: Escalating Prevalence Of Respiratory Disorders Is Driving Factors Behind The Growth Of The Pulmonary Drug Delivery Devices Market

• Market Trend: Innovation In Pulmonary Drug Delivery Devices

North America was the largest region in 2025.

What Is Covered Under Pulmonary Drug Delivery Devices Market?

Pulmonary drug delivery devices are inhalation devices used to deliver medications directly to the lungs. These devices allow for targeted delivery of drugs to treat respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD). Pulmonary delivery also enables systemic absorption of drugs like insulin and pain medications.

The main product types of pulmonary drug delivery devices included are dry powder inhalers, metered dose inhalers, and nebulizers. Dry powder inhalers are devices that deliver a measured dose of medication in the form of a fine, dry powder that the patient inhales directly into their lungs. It is provided for applications such as asthma, cystic fibrosis, chronic obstructive pulmonary disease, and others and is sold through distribution channels such as retail pharmacies, hospital pharmacies, and e-commerce.

Pulmonary Drug Delivery Devices market report bar graph

What Is The Pulmonary Drug Delivery Devices Market Size and Share 2026?

The pulmonary drug delivery devices market size has grown strongly in recent years. It will grow from $52.8 billion in 2025 to $56.49 billion in 2026 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to increasing prevalence of respiratory diseases, rising use of inhalation therapies, expansion of asthma and copd treatment programs, improvements in inhaler design technologies, growing awareness of pulmonary drug delivery.

What Is The Pulmonary Drug Delivery Devices Market Growth Forecast?

The pulmonary drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $71.9 billion in 2030 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to increasing demand for personalized respiratory therapies, rising adoption of digital health integrated inhalers, expansion of home-based respiratory care, growing focus on non-invasive drug delivery, continued innovation in inhalation technologies. Major trends in the forecast period include increasing adoption of smart and connected inhaler devices, rising demand for targeted pulmonary drug delivery, growing use of mesh and ultrasonic nebulizers, expansion of combination drug-device products, enhanced focus on patient adherence.

Customer representative image Book your 30 minutes free consultation with our research experts

Global Pulmonary Drug Delivery Devices Market Segmentation

1) By Product Type: Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers

2) By Application: Asthma, Cystic Fibrosis, Chronic Obstructive Pulmonary Disease, Other Applications

3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, E-Commerce

Subsegments:

1) By Dry Powder Inhalers (DPIs): Single-Dose DPIs, Multi-Dose DPIs

2) By Metered Dose Inhalers (MDIs): CFC-Based MDIs, HFA-Based MDIs

3) By Nebulizers: Jet Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers

What Is The Driver Of The Pulmonary Drug Delivery Devices Market?

The escalating prevalence of respiratory disorders is expected to propel the growth of the pulmonary drug delivery devices market going forward. Respiratory disorders refer to diseases or conditions that affect the lungs and airways, impacting human respiration. There is an increasing prevalence of respiratory disorders due to several factors such as rising levels of air pollution, increasing smoking rates, urbanization, climate change, and the aging population. Pulmonary drug delivery devices play an important role in the treatment of respiratory disorders by allowing direct delivery of medications to the lungs. For instance, in December 2023, according to a research study published by JAMA Network Open, a medical journal by the American Medical Association, the global burden of chronic obstructive pulmonary disease (COPD) projected that the cases worldwide could reach nearly 600 million by 2050, marking a 23% increase in prevalence. Therefore, the rising prevalence of COPD is driving the growth of the pulmonary drug delivery devices industry.

Key Players In The Global Pulmonary Drug Delivery Devices Market

Major companies operating in the pulmonary drug delivery devices market are Medtronic plc, Air Liquide S.A., Becton Dickinson And Company, Koninklijke Philips N.V., Medline Industries Inc., ResMed Inc., Drägerwerk AG And Co. KGaA, Smiths Group plc, AptarGroup Inc., Chiesi Farmaceutici S.p.A., Teleflex Incorporated, Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hovione, Hamilton Medical AG, GaleMed Corporation, Allied Healthcare Products Inc., Precision Medical Inc., Salter Labs Inc.

Global Pulmonary Drug Delivery Devices Market Trends and Insights

Major companies operating in the pulmonary drug delivery devices market are developing innovative products, such as small-volume nebulizers, to better serve customers with advanced features. A small-volume nebulizer (SVN) is a medical device used to deliver liquid medication in the form of aerosolized mist to patients with respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), or cystic fibrosis. For instance, in May 2024, Medline Industries LP, a US-based healthcare company, launched the Hudson RCI TurboMist small-volume nebulizer. This groundbreaking device is designed to deliver medication treatments quickly, in as little as three minutes. The innovative nebulizer can dispense 2.5 times more medication per minute compared to standard nebulizers, reducing treatment times by about 70%. This increase in medication delivery significantly reduces treatment times, benefiting healthcare providers by optimizing patient throughput and enhancing the patient experience by shortening the duration of therapy sessions.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Pulmonary Drug Delivery Devices Market?

In January 2025, Molex LLC, a US-based electronics and manufacturing company, acquired Vectura Group Ltd. for an undisclosed amount. With this acquisition, Phillips Medisize, Molex’s CDMO arm, significantly bolsters its inhalation drug-delivery capabilities, enabling a broader portfolio of combination products and device development. Vectura Group Limited is a UK-based pharmaceutical technology company that specializes in providing pulmonary drug delivery devices.

Regional Outlook

North America was the largest region in the pulmonary drug delivery devices market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Pulmonary Drug Delivery Devices Market?

The pulmonary drug delivery devices market consists of sales of jet nebulizers, ultrasonic wave nebulizers, and vibrating mesh nebulizers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pulmonary Drug Delivery Devices Market Report 2026?

The pulmonary drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pulmonary drug delivery devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Pulmonary Drug Delivery Devices Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $56.49 billion
Revenue Forecast In 2035 $71.9 billion
Growth Rate CAGR of 7.0% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Product Type, Application, Distribution Channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Medtronic plc, Air Liquide S.A., Becton Dickinson And Company, Koninklijke Philips N.V., Medline Industries Inc., ResMed Inc., Drägerwerk AG And Co. KGaA, Smiths Group plc, AptarGroup Inc., Chiesi Farmaceutici S.p.A., Teleflex Incorporated, Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hovione, Hamilton Medical AG, GaleMed Corporation, Allied Healthcare Products Inc., Precision Medical Inc., Salter Labs Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Pulmonary Drug Delivery Devices Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Pulmonary Drug Delivery Devices Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Pulmonary Drug Delivery Devices Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Pulmonary Drug Delivery Devices Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Sustainability, Climate Tech & Circular Economy

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Artificial Intelligence & Autonomous Intelligence

4.2. Major Trends

4.2.1 Increasing Adoption Of Smart And Connected Inhaler Devices

4.2.2 Rising Demand For Targeted Pulmonary Drug Delivery

4.2.3 Growing Use Of Mesh And Ultrasonic Nebulizers

4.2.4 Expansion Of Combination Drug-Device Products

4.2.5 Enhanced Focus On Patient Adherence

5. Pulmonary Drug Delivery Devices Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Pulmonology Clinics

5.3 Home Healthcare Providers

5.4 Retail Pharmacies

5.5 Hospital Pharmacies

6. Pulmonary Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pulmonary Drug Delivery Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Pulmonary Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Pulmonary Drug Delivery Devices Market Size, Comparisons And Growth Rate Analysis

7.3. Global Pulmonary Drug Delivery Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Pulmonary Drug Delivery Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pulmonary Drug Delivery Devices Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pulmonary Drug Delivery Devices Market Segmentation

9.1. Global Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers

9.2. Global Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Asthma, Cystic Fibrosis, Chronic Obstructive Pulmonary Disease, Other Applications

9.3. Global Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Retail Pharmacies, Hospital Pharmacies, E-Commerce

9.4. Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Dry Powder Inhalers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Single-Dose DPIs, Multi-Dose DPIs

9.5. Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Metered Dose Inhalers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

CFC-Based MDIs, HFA-Based MDIs

9.6. Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Nebulizers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Jet Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers

10. Pulmonary Drug Delivery Devices Market Regional And Country Analysis

10.1. Global Pulmonary Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Pulmonary Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pulmonary Drug Delivery Devices Market

11.1. Asia-Pacific Pulmonary Drug Delivery Devices Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pulmonary Drug Delivery Devices Market

12.1. China Pulmonary Drug Delivery Devices Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pulmonary Drug Delivery Devices Market

13.1. India Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pulmonary Drug Delivery Devices Market

14.1. Japan Pulmonary Drug Delivery Devices Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pulmonary Drug Delivery Devices Market

15.1. Australia Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pulmonary Drug Delivery Devices Market

16.1. Indonesia Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pulmonary Drug Delivery Devices Market

17.1. South Korea Pulmonary Drug Delivery Devices Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pulmonary Drug Delivery Devices Market

18.1. Taiwan Pulmonary Drug Delivery Devices Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pulmonary Drug Delivery Devices Market

19.1. South East Asia Pulmonary Drug Delivery Devices Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pulmonary Drug Delivery Devices Market

20.1. Western Europe Pulmonary Drug Delivery Devices Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pulmonary Drug Delivery Devices Market

21.1. UK Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pulmonary Drug Delivery Devices Market

22.1. Germany Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pulmonary Drug Delivery Devices Market

23.1. France Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pulmonary Drug Delivery Devices Market

24.1. Italy Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pulmonary Drug Delivery Devices Market

25.1. Spain Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pulmonary Drug Delivery Devices Market

26.1. Eastern Europe Pulmonary Drug Delivery Devices Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pulmonary Drug Delivery Devices Market

27.1. Russia Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pulmonary Drug Delivery Devices Market

28.1. North America Pulmonary Drug Delivery Devices Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pulmonary Drug Delivery Devices Market

29.1. USA Pulmonary Drug Delivery Devices Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pulmonary Drug Delivery Devices Market

30.1. Canada Pulmonary Drug Delivery Devices Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pulmonary Drug Delivery Devices Market

31.1. South America Pulmonary Drug Delivery Devices Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pulmonary Drug Delivery Devices Market

32.1. Brazil Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pulmonary Drug Delivery Devices Market

33.1. Middle East Pulmonary Drug Delivery Devices Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pulmonary Drug Delivery Devices Market

34.1. Africa Pulmonary Drug Delivery Devices Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pulmonary Drug Delivery Devices Market Regulatory and Investment Landscape

36. Pulmonary Drug Delivery Devices Market Competitive Landscape And Company Profiles

36.1. Pulmonary Drug Delivery Devices Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Pulmonary Drug Delivery Devices Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Pulmonary Drug Delivery Devices Market Company Profiles

36.3.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Air Liquide S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Becton Dickinson And Company Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Medline Industries Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Pulmonary Drug Delivery Devices Market Other Major And Innovative Companies

ResMed Inc., Drägerwerk AG And Co. KGaA, Smiths Group plc, AptarGroup Inc., Chiesi Farmaceutici S.p.A., Teleflex Incorporated, Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hovione, Hamilton Medical AG, GaleMed Corporation, Allied Healthcare Products Inc.

38. Global Pulmonary Drug Delivery Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pulmonary Drug Delivery Devices Market

40. Pulmonary Drug Delivery Devices Market High Potential Countries, Segments and Strategies

40.1 Pulmonary Drug Delivery Devices Market In 2030 - Countries Offering Most New Opportunities

40.2 Pulmonary Drug Delivery Devices Market In 2030 - Segments Offering Most New Opportunities

40.3 Pulmonary Drug Delivery Devices Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Pulmonary Drug Delivery Devices Market, Overview Of Key Products - Product Examples
  • Table 2: Global Pulmonary Drug Delivery Devices Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Pulmonary Drug Delivery Devices Market, Supply Chain Analysis
  • Table 4: Global Pulmonary Drug Delivery Devices Market, Major Raw Material Providers
  • Table 5: Global Pulmonary Drug Delivery Devices Market, Major Resource Providers
  • Table 6: Global Pulmonary Drug Delivery Devices Market, Major Manufacturers (Suppliers)
  • Table 7: Global Pulmonary Drug Delivery Devices Market, Major Distributors And Channel Partners
  • Table 8: Global Pulmonary Drug Delivery Devices Market, Key Technologies & Future Trends
  • Table 9: Global Pulmonary Drug Delivery Devices Market, Major Trends
  • Table 10: Global Pulmonary Drug Delivery Devices Market, Major End Users
  • Table 11: Global Pulmonary Drug Delivery Devices Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Pulmonary Drug Delivery Devices Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Pulmonary Drug Delivery Devices Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Pulmonary Drug Delivery Devices Market - TAM, US$ Billion, 2025
  • Table 15: Global Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Dry Powder Inhalers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Metered Dose Inhalers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Nebulizers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Pulmonary Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Pulmonary Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global Pulmonary Drug Delivery Devices Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global Pulmonary Drug Delivery Devices Market - Company Scoring Matrix
  • Table 97: Medtronic plc Financial Performance
  • Table 98: Air Liquide S.A. Financial Performance
  • Table 99: Becton Dickinson And Company Financial Performance
  • Table 100: Koninklijke Philips N.V. Financial Performance
  • Table 101: Medline Industries Inc. Financial Performance
  • Table 102: Global Pulmonary Drug Delivery Devices Market, Competitive Benchmarking (In USD Billions)
  • Table 103: Global Pulmonary Drug Delivery Devices Market, Competitive Dashboard
  • Table 104: Global Pulmonary Drug Delivery Devices Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 105: Global, Pulmonary Drug Delivery Devices Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030
  • Table 106: Global, Pulmonary Drug Delivery Devices Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030
  • Table 107: Global, Pulmonary Drug Delivery Devices Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

    Figure 1: Global Pulmonary Drug Delivery Devices Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Pulmonary Drug Delivery Devices Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Pulmonary Drug Delivery Devices Market, Supply Chain Analysis
  • Figure 4: Global Pulmonary Drug Delivery Devices Market, Major Raw Material Providers
  • Figure 5: Global Pulmonary Drug Delivery Devices Market, Major Resource Providers
  • Figure 6: Global Pulmonary Drug Delivery Devices Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Pulmonary Drug Delivery Devices Market, Major Distributors And Channel Partners
  • Figure 8: Global Pulmonary Drug Delivery Devices Market, Key Technologies & Future Trends
  • Figure 9: Global Pulmonary Drug Delivery Devices Market, Major Trends
  • Figure 10: Global Pulmonary Drug Delivery Devices Market, Major End Users
  • Figure 11: Global Pulmonary Drug Delivery Devices Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Pulmonary Drug Delivery Devices Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Pulmonary Drug Delivery Devices Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Pulmonary Drug Delivery Devices Market - TAM, US$ Billion, 2025
  • Figure 15: Global Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Dry Powder Inhalers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Metered Dose Inhalers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Pulmonary Drug Delivery Devices Market, Sub-Segmentation Of Nebulizers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Pulmonary Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Pulmonary Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Pulmonary Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Pulmonary Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Pulmonary Drug Delivery Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global Pulmonary Drug Delivery Devices Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global Pulmonary Drug Delivery Devices Market - Company Scoring Matrix
  • Figure 97: Medtronic plc Financial Performance
  • Figure 98: Air Liquide S.A. Financial Performance
  • Figure 99: Becton Dickinson And Company Financial Performance
  • Figure 100: Koninklijke Philips N.V. Financial Performance
  • Figure 101: Medline Industries Inc. Financial Performance
  • Figure 102: Global Pulmonary Drug Delivery Devices Market, Competitive Benchmarking (In USD Billions)
  • Figure 103: Global Pulmonary Drug Delivery Devices Market, Competitive Dashboard
  • Figure 104: Global Pulmonary Drug Delivery Devices Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 105: Global, Pulmonary Drug Delivery Devices Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030
  • Figure 106: Global, Pulmonary Drug Delivery Devices Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030
  • Figure 107: Global, Pulmonary Drug Delivery Devices Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Frequently Asked Questions

The Pulmonary Drug Delivery Devices market was valued at $52.8 billion in 2025, increased to $56.49 billion in 2026, and is projected to reach $71.9 billion by 2030.

The global Pulmonary Drug Delivery Devices market is expected to grow at a CAGR of 6.2% from 2026 to 2035 to reach $71.9 billion by 2035.

Some Key Players in the Pulmonary Drug Delivery Devices market Include, Medtronic plc, Air Liquide S.A., Becton Dickinson And Company, Koninklijke Philips N.V., Medline Industries Inc., ResMed Inc., Drägerwerk AG And Co. KGaA, Smiths Group plc, AptarG

Major trend in this market includes: Innovation In Pulmonary Drug Delivery Devices. For further insights on this market. request a sample here

North America was the largest region in the pulmonary drug delivery devices market in 2025. The regions covered in the pulmonary drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, S

Customer representative image Book your 30 minutes free consultation with our research experts